Century Therapeutics (IPSC) Interest & Investment Income (2022 - 2026)
Century Therapeutics (IPSC) posted quarterly Interest & Investment Income of $2.0 million for Q1 2026, down 16.64% year-over-year from $2.4 million in Q1 2025, and up 54.24% quarter-over-quarter from $1.3 million in Q4 2025.
Century Therapeutics (IPSC) Interest & Investment Income (2022 - 2026) Analysis & Trends
Century Therapeutics (IPSC) has reported Interest & Investment Income for 5 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income fell 16.64% year-over-year to $2.0 million; the TTM figure through Mar 2026 stood at $6.9 million (down 43.04% YoY), while the FY2025 annual figure was $7.3 million, down 43.52% from the prior year.
- Interest & Investment Income rose to $2.0 million in Q1 2026 per IPSC's latest filing, from $1.3 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $3.6 million in Q2 2024 and bottomed at $706000.0 in Q2 2022.
- Historically, Interest & Investment Income has averaged $2.5 million across 5 years, with a median of $2.6 million in 2023.
- Annual changes were most pronounced in 2023 — Interest & Investment Income soared 333.14% — and 2025, when it tumbled 54.56%.
- Century Therapeutics' Interest & Investment Income stood at $1.4 million in 2022, then soared by 148.76% to $3.5 million in 2023, then declined by 17.92% to $2.9 million in 2024, then sank by 54.56% to $1.3 million in 2025, then soared by 54.24% to $2.0 million in 2026.
- Business Quant data shows IPSC's Interest & Investment Income at $2.0 million in Q1 2026, $1.3 million in Q4 2025, and $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 120.60 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -48.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 48.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 35.58 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 27.90 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 5.13 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 28.14 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 10.98 Mn |
| 10 | Century Therapeutics | 346.65 Mn | 86.58 Mn | - | 1.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.98 Mn |
| Mar 31, 2026 | 2.02 Mn |
| Dec 31, 2025 | 1.31 Mn |
| Sep 30, 2025 | 1.61 Mn |
| Jun 30, 2025 | 2.01 Mn |
| Mar 31, 2025 | 2.42 Mn |
| Dec 31, 2024 | 2.88 Mn |
| Sep 30, 2024 | 3.31 Mn |
| Jun 30, 2024 | 3.58 Mn |
| Mar 31, 2024 | 3.24 Mn |
| Dec 31, 2023 | 3.51 Mn |
| Sep 30, 2023 | 3.49 Mn |
| Jun 30, 2023 | 3.06 Mn |
| Mar 31, 2023 | 2.62 Mn |
| Sep 30, 2022 | 1.41 Mn |
| Jun 30, 2022 | 706,000.00 |